Anixa 生物科學公司
US ˙ NasdaqCM ˙ US03528H1095

SecurityANIX / Anixa Biosciences, Inc.
InstitutionBlackRock, Inc.
Latest Disclosed Ownership170,103 shares
Latest Disclosed Value $ 438,865
BlackRock, Inc. reports 3.73% increase in ownership of ANIX / Anixa Biosciences, Inc.

On May 13, 2026 - BlackRock, Inc. filed a 13F-HR form disclosing ownership of 170,103 shares of Anixa Biosciences, Inc. (US:ANIX) valued at $438,866 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 163,983 shares of Anixa Biosciences, Inc.. This represents a change in shares of 3.73% during the quarter. The current value of the position is $421,855 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ANIXA BIOSCIENCES COM 03528H109 170,103 6,120 3.73 439 -14.29 0.0000
2026-02-12 2025-12-31 13F ANIXA BIOSCIENCES COM 03528H109 163,983 2,961 1.84 512 -3.77 0.0000
2025-11-12 2025-09-30 13F ANIXA BIOSCIENCES COM 03528H109 161,022 1,554 0.97 531 0.95 0.0000
2025-08-12 2025-06-30 13F ANIXA BIOSCIENCES COM 03528H109 159,468 -35,955 -18.40 526 -5.73 0.0000
2025-05-02 2025-03-31 13F ANIXA BIOSCIENCES COM 03528H109 195,423 12,391 6.77 559 31.60 0.0000
2025-02-07 2024-12-31 13F ANIXA BIOSCIENCES COM 03528H109 183,032 20,691 12.75 425 -17.03 0.0000
2024-11-13 2024-09-30 13F ANIXA BIOSCIENCES COM 03528H109 162,341 1,925 1.20 511 44.35 0.0000
2024-08-13 2024-06-30 13F ANIXA BIOSCIENCES COM 03528H109 160,416 5,754 3.72 355 -26.56 0.0000
2024-05-10 2024-03-31 13F ANIXA BIOSCIENCES COM 03528H109 154,662 -2,135 -1.36 483 -20.72 0.0000
2024-02-13 2023-12-31 13F ANIXA BIOSCIENCES COM 03528H109 156,797 -4,769 -2.95 608 15.15 0.0000
2023-11-13 2023-09-30 13F ANIXA BIOSCIENCES COM 03528H109 161,566 -90,004 -35.78 528 -34.41 0.0000
2023-08-11 2023-06-30 13F ANIXA BIOSCIENCES COM 03528H109 251,570 4,210 1.70 805 -24.27 0.0000
2023-05-12 2023-03-31 13F ANIXA BIOSCIENCES COM 03528H109 247,360 -46,859 -15.93 1,064 -14.96 0.0000
2023-02-13 2022-12-31 13F ANIXA BIOSCIENCES COM 03528H109 294,219 -3,294 -1.11 1,250 -14.62 0.0000
2022-11-14 2022-09-30 13F ANIXA BIOSCIENCES COM 03528H109 297,513 195,603 191.94 1,464 370.74 0.0000
2022-08-12 2022-06-30 13F ANIXA BIOSCIENCES COM 03528H109 101,910 -54 -0.05 311 11.47 0.0000
2022-05-12 2022-03-31 13F ANIXA BIOSCIENCES COM 03528H109 101,964 -3,204 -3.05 279 -10.58 0.0000
2022-02-10 2021-12-31 13F ANIXA BIOSCIENCES COM 03528H109 105,168 -5,124 -4.65 312 -40.57 0.0000
2021-11-09 2021-09-30 13F ANIXA BIOSCIENCES COM 03528H109 110,292 -7,737 -6.56 525 14.63 0.0000
2021-08-11 2021-06-30 13F ANIXA BIOSCIENCES COM 03528H109 118,029 15,809 15.47 458 -4.18 0.0000
2021-05-07 2021-03-31 13F ANIXA BIOSCIENCES COM 03528H109 102,220 8,278 8.81 478 65.40 0.0000
2021-02-05 2020-12-31 13F ANIXA BIOSCIENCES COM 03528H109 93,942 6,964 8.01 289 36.32 0.0000
2020-11-06 2020-09-30 13F ANIXA BIOSCIENCES COM 03528H109 86,978 -1,201 -1.36 212 -21.77 0.0000
2020-08-14 2020-06-30 13F ANIXA BIOSCIENCES COM 03528H109 88,179 8,198 10.25 271 111.72 0.0000
2020-05-01 2020-03-31 13F ANIXA BIOSCIENCES COM 03528H109 79,981 -1,117 -1.38 128 -51.88 0.0000
2020-02-13 2019-12-31 13F ANIXA BIOSCIENCES COM 03528H109 81,098 -4,891 -5.69 266 -22.67 0.0000
2019-11-08 2019-09-30 13F ANIXA BIOSCIENCES COM 03528H109 85,989 6,315 7.93 344 19.03 0.0000
2019-08-22 2019-06-30 13F/A-1 ANIXA BIOSCIENCES COM 03528H109 79,674 29,823 59.82 289 28.44 0.0000
2019-08-13 2019-06-30 13F ANIXA BIOSCIENCES COM 03528H109 79,674 29,823 289
2019-05-09 2019-03-31 13F ANIXA BIOSCIENCES COM 03528H109 49,851 -2,545 -4.86 225 9.22 0.0000
2019-02-08 2018-12-31 13F ANIXA BIOSCIENCES COM 03528H109 52,396 263 0.50 206 -14.88 0.0000
2018-11-09 2018-09-30 13F ITUS COM NEW 45069V203 52,133 6,565 14.41 242 74.10 0.0000
2018-08-09 2018-06-30 13F ITUS COM NEW 45069V203 45,568 40,748 845.39 139 631.58 0.0000
2018-05-09 2018-03-31 13F ITUS COM NEW 45069V203 4,820 0 0.00 19 72.73 0.0000
2018-02-09 2017-12-31 13F ITUS COM NEW 45069V203 4,820 0 0.00 11 -15.38 0.0000
2017-11-14 2017-09-30 13F ITUS COM NEW 45069V203 4,820 0 0.00 13 116.67 0.0000
2017-08-10 2017-06-30 13F ITUS COM NEW 45069V203 4,820 0 0.00 6 -57.14 0.0000
2017-05-12 2017-03-31 13F ITUS COM NEW 45069V203 4,820 4,820 14 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.